Major Areas of Activity for Deep Pharma Intelligence​

Artificial Intelligence (AI) in the Pharmaceutical and BioTech research and commercialization

Vaccines, Immunization, Preventive Medicine

M&A landscape profiling to assist pipeline development strategies

Discovery and development of the emerging therapeutic modalities

Trends in clinical trials and translational medicine (including AI-driven real world evidence strategies)

Promising BioTech startups and business analytics

Emerging technologies and trends in Precision Medicine (NanoTech, cell therapies, gene therapies, etc)

Digital health technologies (AI-augmented diagnostics, IoT, etc)

Viral and antibiotics therapeutics (including COVID-19)